Table S4 shows the relationship between A-2-C-CT HA and various clinical characteristics. The clinicopathological data were compared between the two groups; results indicated that T stage, N stage, M stage, therapeutic segment (TS), pro-GRP, and BM were associated with A-2-C-CT HA (all p < 0.05); sex, age, smoking history, illness history, ECOG-PS, LM, clinical efficacy, adrenal metastasis (AM), CEA, NSE, SCC, CYFRA21-1, and IM were not associated with A-2-C-CT HA (all p > 0.05) (Table S4). The gene discussed is CEACAM5; the disease is acute myeloblastic leukemia with maturation.